Alzheimer’s Disease Clinical Research Program

Focused research across the Alzheimer’s continuum, guided by scientific rigor and patient safety.

ACTC

ACTC-Aligned Alzheimer’s Clinical Research

Melgar-Caro Medical Center & Community Research (MCMCR) conducts ethically responsible, scientifically rigorous Alzheimer’s disease clinical trials across the full disease continuum. As an ACTC member site, our research prioritizes participant safety, data integrity, and high-quality clinical trial execution from preclinical stages through advanced dementia.

Alzheimer’s Disease Trials by Stage

MCMCR conducts clinical trials across the Alzheimer’s disease spectrum, including:

Preclinical Alzheimer’s Disease: (Biomarker-positive individuals without cognitive symptoms)

Prodromal Alzheimer’s / Mild Cognitive Impairment (MCI) due to Alzheimer’s

Mild to Moderate Alzheimer’s Dementia

Moderate to Severe Alzheimer’s Dementia

Neuropsychiatric and Behavioral Symptoms of Alzheimer’s Disease: (including apathy, agitation, and other behavioral symptoms)

Research Capabilities

Clinical & Biomarkers

Brain MRI (3T)
Dedicated infusion center
Plasma biomarker sampling
PET imaging (amyloid and tau)
Dedicated, trained Alzheimer’s disease raters
Lumbar puncture and cerebrospinal fluid (CSF) biomarker collection

Operational

Research pharmacy support (PharmD-led)
Alzheimer’s disease principal investigators
ACTC-experienced clinical research operations
Participant recruitment and retention strategies
Clinical research coordinators (CRCs) and research nurses
Collaboration with imaging, laboratory, and specialty vendors

MCMCR collaborates with:

Pharmaceutical and biotechnology companies
Contract Research Organizations (CROs)
Consortium-based research networks
Imaging and biomarker partners

Our site is experienced in early-phase, proof-of-concept, and late-phase Alzheimer’s disease trials.

View Research Opportunities

Sponsors & CROs

MCMCR is actively interested in collaborating on Alzheimer’s disease clinical trials across the therapeutic pipeline.
Contact us to discuss feasibility, site capabilities, and collaboration opportunities.

ACTC affiliation is provided for informational purposes only and does not imply endorsement of specific clinical trials or sponsors.

Interested in Participating in an Alzheimer’s Research Study?

Individuals and families may be eligible to participate in Alzheimer’s disease clinical research studies depending on memory symptoms, medical history, and biomarker status. Participation is voluntary and all studies are conducted under strict ethical and regulatory oversight.
Contact us to learn more about current research opportunities.

"*" indicates required fields